IperionX Limited
IperionX Limited (IPX) Financial Performance & Income Statement Overview
Review IperionX Limited (IPX) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
IperionX Limited (IPX) Income Statement & Financial Overview
Analyze IperionX Limited’s IPX earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $2475.00 | $2475.00 | $1882.00 | $1882.00 |
| SG&A Expenses | $3774.00 | $3774.00 | $3178.00 | $3178.00 |
| Operating Expenses | $6248.00 | $6248.00 | $5322.00 | $5322.00 |
| Total Costs & Expenses | $6248.00 | $6248.00 | $5322.00 | $5322.00 |
| Interest Income | $0.00 | $0.00 | $74.00 | $74.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $31.00 | $44.00 | $44.00 | $44.00 |
| EBITDA | -$6217.00 | -$6204.00 | -$5016.00 | -$5016.00 |
| EBITDA Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$6248.00 | -$6248.00 | -$5060.00 | -$5060.00 |
| Operating Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | $574.00 | $574.00 | -$187.00 | -$187.00 |
| Income Before Tax | -$5674.00 | -$5674.00 | -$5248.00 | -$5248.00 |
| Income Before Tax Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$43232.00 |
| Net Income | -$5674.00 | -$5674.00 | -$5248.00 | -$5248.00 |
| Net Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS | $0.00 | $0.00 | $0.00 | $0.00 |
| Diluted EPS | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Avg Shares Outstanding | $225.79M | $213.87M | $209.90M | $209.90M |
| Weighted Avg Shares Outstanding (Diluted) | $225.78M | $213.87M | $209.90M | $209.90M |
The company's financials show resilient growth, with revenue advancing from $0.00 in Q1 2024 to $0.00 in Q4 2024. Gross profit remained healthy with margins at N/A in Q4 2024 compared to N/A in Q1 2024. Operating income hit -$6248.00 last quarter, sustaining a consistent N/A margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$6217.00. Net income rose to -$5674.00, while earnings per share reached $0.00. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan